Literature DB >> 19858597

Gastrointestinal Non-Hodgkin's lymphoma: a clinico-pathological study.

Fatin M Al-Sayes1.   

Abstract

OBJECTIVES: The aim of this study is to determine the clinico-pathological features of primary gastrointestinal non-Hodgkin's lymphoma (GI NHL) at King Abdulaziz University Hospital, Jeddah, and to compare our results to those reported in the literature.
MATERIALS AND METHODS: Twenty-three adult patients with primary GI NHL diagnosed over a 5-year period (2000 through 2005) were retrospectively studied clinically and histopathologically. They were classified using the REAL/WHO histopathologic classification.
RESULTS: Of the 23 patients with primary GI NHL, 14 (60.9%) were Saudis, with a male-to-female ratio of 1.3:1. The mean age of male patients was 61. 3 years, ranging from 42-83 years with an SD of +/-13.09; while for females, the mean age was 64 years, ranging from 50-75 years with an SD of +/-9.14. Abdominal pain was the most common presenting symptom (78.3%), and the most common primary site was the stomach (73.9%), followed by the small bowel (13%). The most frequent histologic subtype was the diffuse large B cell lymphoma, accounting for 60.9% of all cases, followed by the marginal-zone cell lymphoma (MALT type), which was Helicobacter pylori associated (39.1%). A large proportion of patients with primary GI NHL had early disease (Stage IE - 20%, Stage IIE - 58.6%). With regards to treatment, 15 patients (65.2%) had chemotherapy, while only 2 patients (8.7%) were treated by Helicobacter pylori eradication. The overall 5-year survival was 47.8%.
CONCLUSION: The data demonstrated that primary GI NHL is more common among males, mainly in their sixth decade. Abdominal pain is the most common presenting symptom, with stomach being the most common involved site. Diffuse large B cell lymphoma is the most frequent histologic subtype, followed by extranodal marginal-zone B cell lymphoma (MALT type), which was Helicobacter-associated. A majority of cases have early disease (stage IE and IIE), mostly treated by combination chemotherapy.

Entities:  

Year:  2006        PMID: 19858597     DOI: 10.4103/1319-3767.29751

Source DB:  PubMed          Journal:  Saudi J Gastroenterol        ISSN: 1319-3767            Impact factor:   2.485


  3 in total

1.  Gastrointestinal lymphoma in Western Algeria: pattern of distribution and histological subtypes (retrospective study).

Authors:  Soumia Zeggai; Noria Harir; Abdenacer Tou; Miloud Medjamia; Khaira Guenaoui
Journal:  J Gastrointest Oncol       Date:  2016-12

2.  Primary gastrointestinal lymphoma.

Authors:  Amir Aledavood; Mohammad Reza Ghavam Nasiri; Bahram Memar; Soodabeh Shahidsales; Hamid Reza Raziee; Kamran Ghafarzadegan; Samira Mohtashami
Journal:  J Res Med Sci       Date:  2012-05       Impact factor: 1.852

3.  Clinicopathological profile of gastrointestinal lymphomas in Kashmir.

Authors:  Mehnaaz Sultan Khuroo; Summyia Farooq Khwaja; Ajaz Rather; Zhahid Hassan; Ruby Reshi; Naira Sultan Khuroo
Journal:  Indian J Med Paediatr Oncol       Date:  2016 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.